MedTrace Logo

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

NCT00520962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1997

Last updated 2007-08-27

No results posted yet for this study

Summary

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis.

The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be \> 30 years, both gender.

Conditions

  • Diabetes Mellitus, Type 2

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • PierMarco Piatti, MD · IRCSS San Raffaele

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1997-06-30
Completion
2006-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00520962 on ClinicalTrials.gov